Former MD Anderson President Dr. Charles A. LeMaistre Passes Away...
Charles Aubrey “Mickey” LeMaistre, M.D., past president of The University of Texas MD Anderson Cancer Center and a pioneering crusader...
MD Anderson and Guardant Health announce partnership to...
The University of Texas MD Anderson Cancer Center and Guardant Health today announced a multi-year partnership designed to accelerate...
MD Anderson welcomes FDA proposed rule to limit carcinogen...
The University of Texas MD Anderson Cancer Center fully supports the proposed rule released today by the U.S. Food and Drug...
‘Collateral’ lethality may offer new therapeutic approach for...
Cancer cells often delete genes that normally suppress tumor formation. These deletions also may extend to neighboring genes, an event...
MD Anderson Submits Letter to the Editor of Wall Street Journal
Dear Editor:
A reduction in force is something no institution wants to do, and it was something we worked tirelessly to avoid at MD...
MD Anderson and Deerfield Management create Vescor LLC to...
Vescor LLC, a new company focused on discovery and development of autophagy targeted therapeutics for cancer treatment, has been...
MD Anderson and nation’s cancer centers jointly endorse...
As national vaccination rates for the human papillomavirus (HPV) remain low, The University of Texas MD Anderson Cancer Center has...
MD Anderson and EMD Serono enter three-year strategic...
The University of Texas MD Anderson Cancer Center and EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany in the...
MD Anderson and Affimed announce clinical immuno-oncology...
The University of Texas MD Anderson Cancer Center and Affimed N.V., a clinical stage biopharmaceutical company focused on discovering...